Identifiers
Database identifiers and provenance.
- Ligand ID
PTY- PDB
4n31- UniProt (similar protein)
R9TES9- Target protein
- PA1303
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 734.1
- LogP ≤ 5 11.67
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 40
- TPSA ≤ 140 Ų 134.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)CO[P@@](=O)(O)OCCNCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)CO[P@@](=O)(O)OCCN
InChI=1S/C40H80NO8P/c1-3-5-7-9-11-13-15-17-18-19-20-21-23-25-27-29-31-33-40(43)49-38(37-48-50(44,45)47-35-34-41)36-46-39(42)32-30-28-26-24-22-16-14-12-10-8-6-4-2/h38H,3-37,41H2,1-2H3,(H,44,45)/t38-/m1/s1InChI=1S/C40H80NO8P/c1-3-5-7-9-11-13-15-17-18-19-20-21-23-25-27-29-31-33-40(43)49-38(37-48-50(44,45)47-35-34-41)36-46-39(42)32-30-28-26-24-22-16-14-12-10-8-6-4-2/h38H,3-37,41H2,1-2H3,(H,44,45)/t38-/m1/s1
NJGIRBISCGPRPF-KXQOOQHDSA-NNJGIRBISCGPRPF-KXQOOQHDSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF10502
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PTY →
- PDB RCSB structure 4n31 →
- UniProt UniProt R9TES9 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PTY”) →
Other binders for this protein
Quick navigation to other ligands bound to PA1303.
ChEMBL 28
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).